Burke Steven Keith (CIK 1619834) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-04). Recent activity: Sell AKBA (21,582 shares), Sell AKBA (25,375 shares), Sell AKBA (20,701 shares), Buy AKBA (204,000 shares), Sell AKBA (7,144 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 21,582 | $29,999 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 25,375 | $35,271 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 20,701 | $28,774 |
| 2026-02-03 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Buy | 204,000 | $0 |
| 2025-03-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 7,144 | $13,074 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Buy | 194,900 | $0 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 23,270 | $48,867 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 27,236 | $57,196 |
Source: SEC Form 4 filings · as of 2026-02-04